ETV6-RUNX1 and hyperdiploid ALL were highly sensitive to the four drugs commonly used in remission induction (PVDL), recapitulating the known chemotherapy-responsive nature of these subtypes9,10. This evidence concerns the gene ETV6 and acute lymphoblastic leukemia.